Background Image
Know Your Risk

Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is the build up of extra fat in liver cells that is not caused by alcohol. It is normal for the liver to contain some fat, however, if more than 5-10% of the liver's weight is fat, then it is called a fatty liver (steatosis).

Any patient with one or more of the following risk factors is at a greater risk for developing fatty liver disease. Fatty liver disease does not have symptoms, making risk factors even more helpful in determining who should get screened.

Type 2 Diabetes

Hypertension

High Cholesterol

BMI > 30

Of Hispanic Ethnicity

Post-menopausal females

Obesity

Bellaire Clinical Research Inforgraphic Bellaire Clinical Research Inforgraphic

Clinical Study Benefits

  • Free liver screening (FibroScan)
  • Recent blood work
  • Personalized dietary/lifestyle counseling
  • Care from board-certified specialists
  • Close monitoring throughout trial participation
  • Compensation for time and travel
  • No insurance or cost

Why Choose Us?

Bellaire Clinical Research is a premier site management organization specializing in multiple complex therapeutic areas. By advocating for quality, integrity, and diversity in clinical research execution, we are dedicated to advancing unmet areas of medical research and leading pivotal scientific discoveries. Our areas of expertise include:

  • Metabolic dysfunction-associated steatohepatitis (MASH) and MASH-related cirrhosis
  • Alzheimer's Disease, Mild Cognitive Impairment, and age-related neurodegenerative diseases, including brain aging and preclinical Alzheimer's Disease
  • Obesity and obesity-related outcomes
  • Execution in Phase 1-4 Clinical Trials

See if you qualify for our Fatty Liver Disease Clinical Trial today. See If You Qualify